218 related articles for article (PubMed ID: 26758254)
1. Genetic Testing and Post-Testing Decision Making among BRCA-Positive Mutation Women: A Psychosocial Approach.
Hesse-Biber S; An C
J Genet Couns; 2016 Oct; 25(5):978-92. PubMed ID: 26758254
[TBL] [Abstract][Full Text] [Related]
2. Preoperative genetic testing affects surgical decision making in breast cancer patients.
Lokich E; Stuckey A; Raker C; Wilbur JS; Laprise J; Gass J
Gynecol Oncol; 2014 Aug; 134(2):326-30. PubMed ID: 24910453
[TBL] [Abstract][Full Text] [Related]
3. The Genetic Testing Experience of BRCA-Positive Women: Deciding Between Surveillance and Surgery.
Hesse-Biber S
Qual Health Res; 2014 Jun; 24(6):773-789. PubMed ID: 24747286
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
[TBL] [Abstract][Full Text] [Related]
5. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.
Stolier AJ; Fuhrman GM; Mauterer L; Bolton JS; Superneau DW
Breast J; 2004; 10(6):475-80. PubMed ID: 15569201
[TBL] [Abstract][Full Text] [Related]
6. Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.
Litton JK; Westin SN; Ready K; Sun CC; Peterson SK; Meric-Bernstam F; Gonzalez-Angulo AM; Bodurka DC; Lu KH; Hortobagyi GN; Arun BK
Cancer; 2009 Apr; 115(8):1598-604. PubMed ID: 19280625
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution.
Johns D; Agarwal J; Anderson L; Ying J; Kohlmann W
J Womens Health (Larchmt); 2017 Jun; 26(6):702-706. PubMed ID: 27922795
[TBL] [Abstract][Full Text] [Related]
8. Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation.
Wainberg S; Husted J
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):1989-95. PubMed ID: 15598752
[TBL] [Abstract][Full Text] [Related]
9. Maximising survival: the main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2.
Jeffers L; Morrison PJ; McCaughan E; Fitzsimons D
Eur J Oncol Nurs; 2014 Aug; 18(4):411-8. PubMed ID: 24731853
[TBL] [Abstract][Full Text] [Related]
10. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.
Rosenberg SM; Sepucha K; Ruddy KJ; Tamimi RM; Gelber S; Meyer ME; Schapira L; Come SE; Borges VF; Golshan M; Winer EP; Partridge AH
Ann Surg Oncol; 2015 Nov; 22(12):3809-15. PubMed ID: 25930247
[TBL] [Abstract][Full Text] [Related]
11. Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.
Chiba A; Hoskin TL; Hallberg EJ; Cogswell JA; Heins CN; Couch FJ; Boughey JC
Ann Surg Oncol; 2016 Oct; 23(10):3232-8. PubMed ID: 27338744
[TBL] [Abstract][Full Text] [Related]
12. Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer.
Park S; Lee JE; Ryu JM; Kim I; Bae SY; Lee SK; Yu J; Kim SW; Nam SJ
World J Surg; 2018 May; 42(5):1384-1390. PubMed ID: 29147896
[TBL] [Abstract][Full Text] [Related]
13. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
[TBL] [Abstract][Full Text] [Related]
14. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.
Rosenberg SM; Ruddy KJ; Tamimi RM; Gelber S; Schapira L; Come S; Borges VF; Larsen B; Garber JE; Partridge AH
JAMA Oncol; 2016 Jun; 2(6):730-6. PubMed ID: 26867710
[TBL] [Abstract][Full Text] [Related]
16. Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel.
Moran O; Nikitina D; Royer R; Poll A; Metcalfe K; Narod SA; Akbari MR; Kotsopoulos J
Breast Cancer Res Treat; 2017 Jan; 161(1):135-142. PubMed ID: 27798748
[TBL] [Abstract][Full Text] [Related]
17. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
18. Are young women ready for BRCA testing? Comparing attitudes and comprehension of two age groups of healthy Italian women.
Gavaruzzi T; Tasso A; Franiuk M; Varesco L; Lotto L
Patient Educ Couns; 2019 Jun; 102(6):1210-1216. PubMed ID: 30718092
[TBL] [Abstract][Full Text] [Related]
19. "It's not if I get cancer, it's when I get cancer": BRCA-positive patients' (un)certain health experiences regarding hereditary breast and ovarian cancer risk.
Dean M
Soc Sci Med; 2016 Aug; 163():21-7. PubMed ID: 27376595
[TBL] [Abstract][Full Text] [Related]
20. "It was an Emotional Baby": Previvors' Family Planning Decision-Making Styles about Hereditary Breast and Ovarian Cancer Risk.
Dean M; Rauscher EA
J Genet Couns; 2017 Dec; 26(6):1301-1313. PubMed ID: 28138923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
